한글목차

RNA 분석/전사체학의 동향과 예측

세계의 RNA 분석/전사체학 시장 규모는 2024-2030년 CAGR 10.5%로 성장하며, 2030년까지 약 123억 달러에 달할 것으로 예측되고 있습니다. 이 시장의 주요 촉진요인은 맞춤형 의료에 대한 수요의 증가와 제약·바이오 산업의 지속적 성장입니다. 세계의 RNA 분석/전사체학 시장의 미래는 정부기관·학술 센터, 제약·바이오테크놀러지, 병원·진료소, 임상시험수탁기관 시장에 비즈니스 기회가 있으며, 유망시되고 있습니다.

RNA 분석/전사체학 시장 인사이트

Lucintel의 예측에 따르면 Drug Discovery는 이 용도에서 타깃 시퀀스 기반 어프로치의 인기 증가에 의해 예측 기간 중 가장 높은 성장이 전망됩니다.

북미는 구조 기반 약제 설계에 대한 선호도의 증가와 이 지역에 대기업 제약기업 및 바이오파마 기업이 존재하는 것으로 인해 계속 최대 지역을 유지합니다.

아래 11개의 주요 질문에 답변하고 있습니다. :

• Q.1.시장 부문 중 가장 유망하고 고성장인 기회는 무엇인가?
• Q.2.어느 부문이 보다 빠른 페이스로 성장하는가, 또 이유는?
• Q.3.향후 성장이 가속할 것으로 생각되는 지역과 이유는?
• Q.4.시장 역학에 영향을 미치는 주요 요인은 무엇인가? 시장에서 주요 과제와 비즈니스 리스크는?
• Q.5.이 시장에서 비즈니스 리스크와 경쟁의 위협은?
• Q.6.이 시장에서 새로운 동향과 이유는?
• Q.7.시장에서 고객의 수요 변화에는 어떤 것이 있는가?
• Q.8.이 시장에서 새로운 개발과 개발을 선도하고 있는 기업은?
• Q.9.이 시장의 주요 기업은? 주요 기업은 사업 성장을 위해 어떤 전략적 구상을 진행시키고 있는가?
• Q.10.이 시장에서 경쟁 제품은 무엇이며, 재료 및 제품의 대체에 의한 시장 점유율 하락의 위협은 어느 정도인가?
• Q.11.과거 5년간 어떤 M&A가 시행되고, 업계에 어떤 영향을 미쳤는가?

목차

제1장 주요 요약

제2장 세계의 RNA 분석/전사체학 시장 : 시장 역학

• 서론, 배경, 분류
• 공급망
• 업계의 촉진요인과 과제

제3장 시장 동향과 예측 분석 : 2018-2030년

• 거시경제 동향(2018-2023년)과 예측(2024-2030년)
• 세계의 RNA 분석/전사체학 시장 동향(2018-2023년)과 예측(2024-2030년)
• 세계의 RNA 분석/전사체학 시장 : 제품 유형별
  • 소모품
  • 기기
  • 소프트웨어
  • 서비스
• 세계의 RNA 분석/전사체학 시장 : 기술별
  • 실시간 PCR(qPCR)
  • 마이크로어레이
  • 시퀀스
  • 기타
• 세계의 RNA 분석/전사체학 시장 : 용도별
  • Drug Discovery
  • 진단·질환 프로파일링
  • 기타
• 세계의 RNA 분석/전사체학 시장 : 최종 용도별
  • 정부기관·학술 센터
  • 제약·바이오테크놀러지
  • 병원·진료소
  • 임상시험수탁기관
  • 기타

제4장 시장 동향과 예측 분석 : 지역별(2018-2030년)

• 세계의 RNA 분석/전사체학 시장 : 지역별
• 북미의 RNA 분석/전사체학 시장
• 유럽의 RNA 분석/전사체학 시장
• 아시아태평양의 RNA 분석/전사체학 시장
• 기타 지역의 RNA 분석/전사체학 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영상의 통합
• Porter's Five Forces 분석

제6장 성장 기회와 전략적 분석

• 성장 기회 분석
  • 제품 유형별 세계의 RNA 분석/전사체학 시장의 성장 기회
  • 기술별 세계의 RNA 분석/전사체학 시장의 성장 기회
  • 용도별 세계의 RNA 분석/전사체학 시장의 성장 기회
  • 최종 용도별 세계의 RNA 분석/전사체학 시장의 성장 기회
  • 지역별 세계의 RNA 분석/전사체학 시장의 성장 기회
• 세계의 RNA 분석/전사체학 시장에서 새로운 동향
• 전략적 분석
  • 신제품의 개발
  • 세계의 RNA 분석/전사체학 시장의 생산 능력 확대
  • 세계의 RNA 분석/전사체학 시장에서의 합병, 인수, 합병사업
  • 인증과 라이선싱

제7장 유력 기업의 기업 개요

• Agilent Technologies
• F. Hoffmann-La Roche
• Illumina
• QIAGEN
• Thermo Fisher Scientific
• Eurofins Scientific
• Merck KGaA
• Bio-Rad Laboratories
• Pacific Bioscience of California
• Affymetrix

영문목차

RNA Analysis/Transcriptomics Trends and Forecast

The future of the global RNA analysis/transcriptomics market looks promising with opportunities in the government institute & academic center, pharmaceutical & biotechnology, hospital & clinic, and contract research organizations markets. The global RNA analysis/transcriptomics market is expected to reach an estimated $12.3 billion by 2030 with a CAGR of 10.5% from 2024 to 2030. The major drivers for this market are increasing demand for personalized medicine and continual growth of pharmaceutical & biological industries.

A more than 150-page report is developed to help in your business decisions.

RNA Analysis/Transcriptomics by Segment

The study includes a forecast for the global RNA analysis/transcriptomics by product type, technology, application, end use, and region.

RNA Analysis/Transcriptomics Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

• Consumables
• Instruments
• Software
• Services

RNA Analysis/Transcriptomics Market by Technology [Shipment Analysis by Value from 2018 to 2030]:

• Real Time-PCR (qPCR)
• Microarray
• Sequencing
• Others

RNA Analysis/Transcriptomics Market by Application [Shipment Analysis by Value from 2018 to 2030]:

• Drug Discovery
• Diagnostics & Disease Profiling
• Others

RNA Analysis/Transcriptomics Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Government Institutes & Academic Centers
• Pharmaceutical & Biotechnology
• Hospitals & Clinics
• Contract Research Organizations (CROs)
• Others

RNA Analysis/Transcriptomics Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of RNA Analysis/Transcriptomics Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies RNA analysis/transcriptomics companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the RNA analysis/transcriptomics companies profiled in this report include-

• Agilent Technologies
• F. Hoffmann-La Roche
• Illumina
• QIAGEN
• Thermo Fisher Scientific
• Eurofins Scientific
• Merck KGaA
• Bio-Rad Laboratories
• Pacific Bioscience of California
• Affymetrix

RNA Analysis/Transcriptomics Market Insights

Lucintel forecasts that drug discovery is expected to witness highest growth over the forecast period due to growing popularity of targeted sequencing-based approaches in this application.

North America will remain the largest region due to growing preference for structure-based drug designs and existence of major pharma and biopharma companies in the region.

Features of the Global RNA Analysis/Transcriptomics Market

Market Size Estimates: RNA analysis/transcriptomics market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: RNA analysis/transcriptomics market size by various segments, such as by product type, technology, application, end use, and region in terms of value ($B).

Regional Analysis: RNA analysis/transcriptomics market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, technologies, applications, end uses, and regions for the RNA analysis/transcriptomics market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the RNA analysis/transcriptomics market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the RNA analysis/transcriptomics market size?

Answer: The global RNA analysis/transcriptomics market is expected to reach an estimated $12.3 billion by 2030.

Q2. What is the growth forecast for RNA analysis/transcriptomics market?

Answer: The global RNA analysis/transcriptomics market is expected to grow with a CAGR of 10.5% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the RNA analysis/transcriptomics market?

Answer: The major drivers for this market are increasing demand for personalized medicine and continual growth of pharmaceutical & biological industries.

Q4. What are the major segments for RNA analysis/transcriptomics market?

Answer: The future of the RNA analysis/transcriptomics market looks promising with opportunities in the government institute & academic center, pharmaceutical & biotechnology, hospital & clinic, and contract research organizations markets.

Q5. Who are the key RNA analysis/transcriptomics market companies?

Answer: Some of the key RNA analysis/transcriptomics companies are as follows:

• Agilent Technologies
• F. Hoffmann-La Roche
• Illumina
• QIAGEN
• Thermo Fisher Scientific
• Eurofins Scientific
• Merck KGaA
• Bio-Rad Laboratories
• Pacific Bioscience of California
• Affymetrix

Q6. Which RNA analysis/transcriptomics market segment will be the largest in future?

Answer: Lucintel forecasts that drug discovery is expected to witness highest growth over the forecast period due to growing popularity of targeted sequencing-based approaches in this application.

Q7. In RNA analysis/transcriptomics market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region due to growing preference for structure-based drug designs and existence of major pharma and biopharma companies in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the RNA analysis/transcriptomics market by product type (consumables, instruments, software, and services), technology (real time-pcr (qPCR), microarray, sequencing, and others), application (drug discovery, diagnostics & disease profiling, and others), end use (government institutes & academic centers, pharmaceutical & biotechnology, hospitals & clinics, contract research organizations (CROs), and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global RNA Analysis/Transcriptomics Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global RNA Analysis/Transcriptomics Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global RNA Analysis/Transcriptomics Market by Product Type
  • 3.3.1: Consumables
  • 3.3.2: Instruments
  • 3.3.3: Software
  • 3.3.4: Services
• 3.4: Global RNA Analysis/Transcriptomics Market by Technology
  • 3.4.1: Real Time-PCR (qPCR)
  • 3.4.2: Microarray
  • 3.4.3: Sequencing
  • 3.4.4: Others
• 3.5: Global RNA Analysis/Transcriptomics Market by Application
  • 3.5.1: Drug Discovery
  • 3.5.2: Diagnostics & Disease Profiling
  • 3.5.3: Others
• 3.6: Global RNA Analysis/Transcriptomics Market by End Use
  • 3.6.1: Government Institutes & Academic Centers
  • 3.6.2: Pharmaceutical & Biotechnology
  • 3.6.3: Hospitals & Clinics
  • 3.6.4: Contract Research Organizations (CROs)
  • 3.6.5: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global RNA Analysis/Transcriptomics Market by Region
• 4.2: North American RNA Analysis/Transcriptomics Market
  • 4.2.1: North American RNA Analysis/Transcriptomics Market by Application: Drug Discovery, Diagnostics & Disease Profiling, and Others
  • 4.2.2: North American RNA Analysis/Transcriptomics Market by End Use: Government Institutes & Academic Centers, Pharmaceutical & Biotechnology, Hospitals & Clinics, Contract Research Organizations (CROs), and Others
• 4.3: European RNA Analysis/Transcriptomics Market
  • 4.3.1: European RNA Analysis/Transcriptomics Market by Application: Drug Discovery, Diagnostics & Disease Profiling, and Others
  • 4.3.2: European RNA Analysis/Transcriptomics Market by End Use: Government Institutes & Academic Centers, Pharmaceutical & Biotechnology, Hospitals & Clinics, Contract Research Organizations (CROs), and Others
• 4.4: APAC RNA Analysis/Transcriptomics Market
  • 4.4.1: APAC RNA Analysis/Transcriptomics Market by Application: Drug Discovery, Diagnostics & Disease Profiling, and Others
  • 4.4.2: APAC RNA Analysis/Transcriptomics Market by End Use: Government Institutes & Academic Centers, Pharmaceutical & Biotechnology, Hospitals & Clinics, Contract Research Organizations (CROs), and Others
• 4.5: ROW RNA Analysis/Transcriptomics Market
  • 4.5.1: ROW RNA Analysis/Transcriptomics Market by Application: Drug Discovery, Diagnostics & Disease Profiling, and Others
  • 4.5.2: ROW RNA Analysis/Transcriptomics Market by End Use: Government Institutes & Academic Centers, Pharmaceutical & Biotechnology, Hospitals & Clinics, Contract Research Organizations (CROs), and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global RNA Analysis/Transcriptomics Market by Product Type
  • 6.1.2: Growth Opportunities for the Global RNA Analysis/Transcriptomics Market by Technology
  • 6.1.3: Growth Opportunities for the Global RNA Analysis/Transcriptomics Market by Application
  • 6.1.4: Growth Opportunities for the Global RNA Analysis/Transcriptomics Market by End Use
  • 6.1.5: Growth Opportunities for the Global RNA Analysis/Transcriptomics Market by Region
• 6.2: Emerging Trends in the Global RNA Analysis/Transcriptomics Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global RNA Analysis/Transcriptomics Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global RNA Analysis/Transcriptomics Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Agilent Technologies
• 7.2: F. Hoffmann-La Roche
• 7.3: Illumina
• 7.4: QIAGEN
• 7.5: Thermo Fisher Scientific
• 7.6: Eurofins Scientific
• 7.7: Merck KGaA
• 7.8: Bio-Rad Laboratories
• 7.9: Pacific Bioscience of California
• 7.10: Affymetrix